Articles from GOA Therapeutics Corporation

GOA Therapeutics Emerges from Stealth with $15.5 Million in Funding and Unveils GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning
Company presented IND-enabling preclinical data earlier today at the AAST annual meeting
By GOA Therapeutics Corporation · Via GlobeNewswire · September 17, 2026